Kymera Therapeutics, Inc. (KYMR)
121.01
+1.21
(+1.01%)
USD |
NASDAQ |
Aug 24, 16:00
121.01
0.00 (0.00%)
After-Hours: 20:00
Kymera Therapeutics Market Cap : 10.02B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 9.918B |
| August 20, 2026 | 10.06B |
| August 19, 2026 | 10.54B |
| August 18, 2026 | 10.05B |
| August 17, 2026 | 10.05B |
| August 14, 2026 | 9.719B |
| August 13, 2026 | 9.473B |
| August 12, 2026 | 9.440B |
| August 11, 2026 | 9.075B |
| August 10, 2026 | 8.989B |
| August 07, 2026 | 8.901B |
| August 06, 2026 | 8.810B |
| August 05, 2026 | 8.733B |
| August 04, 2026 | 8.642B |
| August 03, 2026 | 8.304B |
| July 31, 2026 | 8.498B |
| July 30, 2026 | 8.794B |
| July 29, 2026 | 8.650B |
| July 28, 2026 | 8.724B |
| July 27, 2026 | 9.044B |
| July 24, 2026 | 9.087B |
| July 23, 2026 | 9.071B |
| July 22, 2026 | 9.068B |
| July 21, 2026 | 9.317B |
| July 20, 2026 | 9.127B |
| Date | Value |
|---|---|
| July 17, 2026 | 9.514B |
| July 16, 2026 | 9.368B |
| July 15, 2026 | 9.379B |
| July 14, 2026 | 9.211B |
| July 13, 2026 | 9.073B |
| July 10, 2026 | 9.808B |
| July 09, 2026 | 9.780B |
| July 08, 2026 | 9.382B |
| July 07, 2026 | 9.799B |
| July 06, 2026 | 9.431B |
| July 02, 2026 | 9.328B |
| July 01, 2026 | 9.385B |
| June 30, 2026 | 9.424B |
| June 29, 2026 | 8.984B |
| June 26, 2026 | 8.886B |
| June 25, 2026 | 9.571B |
| June 24, 2026 | 8.208B |
| June 23, 2026 | 8.074B |
| June 22, 2026 | 8.173B |
| June 18, 2026 | 7.432B |
| June 17, 2026 | 7.388B |
| June 16, 2026 | 7.186B |
| June 15, 2026 | 7.034B |
| June 12, 2026 | 7.085B |
| June 11, 2026 | 6.818B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 12.24B |
| Oncolytics Biotech, Inc. | 105.94M |
| Sangamo Therapeutics, Inc. | 58.95M |
| Sarepta Therapeutics, Inc. | 1.915B |
| Anixa Biosciences, Inc. | 122.97M |
Market Cap Related Metrics
| PS Ratio | 107.45 |
| Price to Book Value | 6.638 |
| Price | 121.01 |
| Earnings Yield | -2.68% |